Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).

They only appeared in public three days ago and already have over half a million listens.

I've never had skill as a filmmaker, so was amazed to make a clip of something you'd previously need a Hollywood special effects team to conjure up. But it's not perfect...

North Korea's supreme leader got sprinkled.

Panic erupted on the flight after a bomb threat note was found.

It might even happen this year.